Form 4: CEO Kevin Clark Receives Equity Grant at Cross Country
Statement of Changes in Beneficial Ownership
Cross Country Healthcare CEO Kevin Clark was granted 138,963 restricted shares of common stock vesting over three years.
Summary
- CEO Kevin Clark acquired 138,963 shares of common stock on March 31, 2026.
- The shares were granted at a price of $0, representing a restricted stock award.
- The award vests in three equal annual installments on March 31, 2027, 2028, and 2029.
- Following this transaction, Mr. Clark's direct beneficial ownership increased to 948,133 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral for the stock price.
Positives
- Alignment of executive interests with long-term shareholder value through multi-year vesting equity.
- Retention of key leadership personnel via structured equity compensation.
Negatives
- Dilutive impact on existing shareholders due to the issuance of new restricted stock units.
Risks
- Potential for executive turnover if performance targets or retention incentives are not met.
- Market volatility affecting the future value of the granted equity.
Future Outlook
The filing does not provide specific forward-looking financial guidance, focusing instead on executive compensation structure.
Industry Context
StockSavvy.ai notes that equity-based compensation remains a standard practice in the healthcare staffing industry to align executive incentives with long-term corporate performance and retention.
Comparison to Industry Standards
- The use of three-year cliff or installment vesting is consistent with standard executive compensation packages for mid-cap healthcare services firms.
- Granting restricted stock units (RSUs) is a common practice among competitors like AMN Healthcare and ASGN Incorporated to ensure leadership stability.
Related Party Transactions
- The filing notes 3,961 shares are held by the spouse of the reporting person.
Stakeholder Impact
- Shareholders may experience minor dilution from the issuance of new shares.
- Employees and investors may view the long-term vesting as a sign of management commitment.
Next Steps
- Vesting of the first installment of 46,321 shares (approx.) on March 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of transaction for the restricted stock grant. |
| 04/02/2026 | Date of filing for the Form 4. |
| 03/31/2027 | First vesting installment date. |
| 03/31/2028 | Second vesting installment date. |
| 03/31/2029 | Third vesting installment date. |
Keywords
CCRN, Cross Country Healthcare, Insider Trading, Form 4, Executive Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.